Sitewide
U of M begins nation's first clinical trial using T-reg cells from cord blood in leukemia treatment
University of Minnesota researchers have initiated a ground breaking clinical trial to determine the optimal dose and safety of T regulatory cells (T-regs) to decrease the risk of immune reactions common in patients undergoing blood and marrow transplantation.
Similar Articles On This Topic:
- Nation's first clinical trial using T-reg cells from cord blood in leukemia treatment
- First successful use of expanded umbilical-cord blood units to treat leukemia
- Clinical trial demonstrates safety of pre-transplant expansion of umbilical cord blood stem cells
- Pivotal national trial uses newest interventional radiology treatment to bust blood clots in legs
- Stem cells from umbilical cord used in the treatment of hepatic diseases
Popular Today:
Science 2.0:
- Science Can Save Crops, Forests And Endangered Animals By Doing This One Thing
- Organic Carbon In Meteorites Came From Mars
- Is That A Dragon In Your Berth Or Are You Just Happy To See Me?
- Are Anthropogenic Pressures Increasing The Speed Of Bacterial Evolution?
- From Towel Day To SpaceX And Transparency Grenades
Recent Articles:
Read Us On Your Kindle:
Create Your Own Releases:
Post new comment